A prior study showed that treatment of esophageal adenocarcinoma and squamous cell carcinoma cell lines with demethylating agents resulted in LTBP4 upregulation and decreased cancer cell migration [29]. Here, LTBP4 is linked to esophageal adenocarcinoma.